NCT05165719View on ClinicalTrials.gov

Validation of 'Corona-T-test' for Assessment of SARS-COV-2-specific T-cell Response After COVID-19 or Vaccination

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

September 21, 2021

Study Completion Date

November 20, 2021

Conditions
SARS-CoV-2 InfectionSARS-CoV-2 Vaccination
Interventions
DIAGNOSTIC_TEST

Corona-T-test

Corona-T-test - a single-color enzymatic ELISpot kit for the detection of interferon-gamma (IFNɣ), produced by the National Research Center for Hematology aiming detection of SARS-CoV-2-specific T cells

Trial Locations (1)

125167

National Research Center for Hematology, Moscow

All Listed Sponsors
collaborator

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

OTHER

collaborator

DNKOM LLC

OTHER

lead

National Research Center for Hematology, Russia

NETWORK